β-glucan content and in vitro bile-acid binding capacity of Agaricus bisporus and Pleurotus spp

Damien Paul Belobrajdic,Henri Brook,Genevieve James-Martin,Welma Stonehouse
DOI: https://doi.org/10.1039/d4fo02416h
IF: 6.3173
2024-08-31
Food & Function
Abstract:The cholesterol lowering properties of oat and barley, attributed to their high β-glucan content, are well established, but it remains unclear whether mushrooms, also rich in β-glucan, exhibit similar functionality. We aimed to quantify the β-glucan content of commonly consumed Australian mushrooms and evaluated their bile acid binding capacity, the primary cholesterol lowering mechanism of β-glucan. Raw, boiled and fried Australian grown Agaricus bisporus (Button, Cup, Flat and Brown mushrooms) and Pleurotus spp (Shimeji and Oyster) along with oats were freeze-dried and the β-glucan content determined. The bile acid binding capacity of these samples were assessed using an in vitro digestion assay. The β-glucan content of freeze-dried raw A. bisporus mushrooms (4.5 to 8.1 g/100g) were similar to that of oats (7.6 g/100g, all p > 0.05), whereas Pleurotus mushrooms contained ~5 times more β-glucan (32.5 – 37.4 g, p <0.05). Boiling increased β-glucan content of Oyster, Button, Flat and Brown mushrooms by 3 - 7% (p 0.05) whereas the bile acid binding capacity of Oyster mushrooms (22%) was lower than oats (p < 0.05). Cooking increased bile acid binding capacity. The cholesterol lowering effects of A. bisporus mushrooms and acceptability of consumption at required levels needs to be confirmed by clinical trials.
biochemistry & molecular biology,food science & technology
What problem does this paper attempt to address?